Quantcast
Home > Quotes > PBE

Invesco Dynamic Biotech & Genome ETF (PBE) Quote & Summary Data

(ETF)
PBE 
$54.29
*  
0.02
0.04%
Get PBE Alerts
*Delayed - data as of Jun. 15, 2018  -  Find a broker to begin trading PBE now


Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
ETF Details
Summary Quote ETF Detail Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
ETF NEWS
ETF Headlines Market Stream
FUNDAMENTALS
Short Interest Dividend History
 Save Stocks

Key Stock Data

Today's High / Low
$ 54.56 / $ 54.21
Share Volume
4,292
90 Day Avg. Daily Volume
141,680
Previous Close
$ 54.31
52 Week High / Low
$ 54.35 / $ 43.0244
Market Cap
542,900,000
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
4,292
90 Day Avg. Daily Volume:
141,680

Trading Range

The current last sale of $54.29 is 26.18% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 54.56 $ 54.35
 Low: $ 54.21 $ 43.0244

Description

The PowerShares Dynamic Biotechnology and Genome Portfolio is based on the Dynamic Biotech and Genome Intellidex Index. The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.


Underlying Index Dynamic Biotechnology & Genome Intellidex Index
Management Fee 0.5
Asset Class equity
Leverage 1
Top Holdings
AMGN Amgen Inc 4.8%
CELG Celgene Corp 4.54%
ENTA Enanta Pharmaceuticals Inc 3.46%
OPK OPKO Health Inc 3.43%
EXEL Exelixis Inc 3.38%
MNTA Momenta Pharmaceuticals Inc 3.38%
GHDX Genomic Health Inc 3.34%
RGEN Repligen Corp 3.32%
ARNA Arena Pharmaceuticals Inc 3.02%
DYAX Dyax Corp 0.13%

Research Brokers before you trade

Want to trade FX?

Analyst Info